Company Profile
Nantong Hengxing Electronic Materials Co., Ltd.(Shanshan Industrial Park Hengxing Electronic Material Manufacturing Co., Ltd) is located in Hai'an Fine Chemical Park covering an area of 37,000 square meters and a construction area of 12,000 square meters. There is superior geographical location and convenient transportation. Our company is a professional manufacturer of aluminium electrolytic capacitor abd formed foil exclusive used chemical materials as acid, ammonium salt, kali salt and solvent in over 50 varieties. Our annual production capacity is over 10,000 tons. In addition, there is powerful technical strength, advanced equipment, complete testing method and reliable product quality. We have set product research center by the invitation of professional experts in famous universities, research institutes and large mineral plants in order to promote new product development. And we carry out ISO9001 quality management standard in our manufacturing. Facing with the competitive market, we constantly enlarge our production scale and our sale network is all around the country nowadays.' WHERE customer_id='us20180832100001626'; UPDATE echemi_db_v0_3.t_e_informal_seller SET company_profile=' HWASUN Biotechnology Co; Ltd. is mainly engage in R&D and production of pharmaceutical intermediates. We have advanced production equipment and inspection instruments. And its operation has being carried out strictly under the supervision of ISO9001 and ISO14001 system. We are devoted to decreasing the production cost, optimizing the artwork, creating and keeping the accomplishment of best environmental, health, and safety performance in the industry.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(+)-2,3-Pinanediol |
Bicyclo[3.1.1]heptane-2,3-diol,2,6,6-trimethyl-,(1S,2S,3R,5S)-;2,3-Pinanediol,(1S,2S,3R,5S)-(+)-;Bicyclo[3.1.1]heptane-2,3-diol,2,6,6-trimethyl-,[1S-(1α,2α,3α,5α)]-;(1S,2S,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol;2α,3α-Pinanediol;(1S,2S,3R,5S)-(+)-Pinanediol;(1S,2S,3R,5S)-(+)-Pinane-2,3-diol;(1S,2S,3R,5S)-2,3-Pinanediol;(+)-Pinanediol;(1S,2S,3R,5S)-(+)-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol;(1S,2S,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol;1860831-78-2 |
18680-27-8 | Inquiry | |
(-)-2,3-Pinanediol |
(-)-2-HYDROXYISOPINOCAMPHEOL;(1R,2R,3S,5R)-(-)-2,3-PINANEDIOL;(1R,2R,3S,5R)-2,3-PINANEDIOL;(1R,2R,3S,5R)-(-)-PINANEDIOL;[1R-(1ALPHA,2ALPHA,3ALPHA,5ALPHA)]-2,6,6-TRIMETHYLBICYCLO[3.1.1]HEPTANE-2,3-DIOL;((1R-(1ALPHA,2BETA,3BETA,5ALPHA))-2,6,6-TRIMETHYLBICYCLO(3.3.1)HEPTANE-2,3-DIOL);(-)-2-Hydroxyisopinocampheol, [1R-(1α,2α,3α,5α)]-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol;(1R,2R,3S,5R)-(-)-2,3-Pinanediol,98% |
22422-34-0 | Inquiry | |
(R)-BoroLeu-(+)-Pinanediol-CF3CO2H |
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine,hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-,(αR,3aS,4S,6S,7aR)-,2,2,2-trifluoroacetate (1:1);4,6-Methano-1,3,2-benzodioxaborole-2-methanamine,hexahydro-3a,5,5-trimethyl-α-(2-methylpropyl)-,[3aS-[2(S*),3aα,4β,6β,7aα]]-,trifluoroacetate;4,6-Methano-1,3,2-benzodioxaborole-2-methanamine,hexahydro-3a,5,5-trimethyl-α-(2-methylpropyl)-,(αR,3aS,4S,6S,7aR)-,trifluoroacetate |
179324-87-9 | Inquiry | |
(S)-1-(3,5-Bis-trifluoromethylphenyl)ethanol |
Benzenemethanol,α-methyl-3,5-bis(trifluoromethyl)-,(αS)-;(αS)-α-Methyl-3,5-bis(trifluoromethyl)benzenemethanol;(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol;(S)-3′,5′-Bis(trifluoromethyl)-1-phenethanol;(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol;(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol;(S)-3,5-Bis (trifluoromethyl) phenethyl alcohol;(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethan-1-ol |
225920-05-8 | Inquiry | |
4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
7H-Pyrrolo[2,3-d]pyrimidine,4-chloro-;1H-Pyrrolo[2,3-d]pyrimidine,4-chloro-;4-Chloro-7H-pyrrolo[2,3-d]pyrimidine;4-Chloropyrrolo[2,3-d]pyrimidine;NSC 64952;6-Chloro-7-deazapurine;4-Chloro-1H-pyrrolo[2,3-d]pyrimidine |
3680-69-1 | Inquiry | |
4-fluoro-4'-morpholinobenzophenone |
330636-27-6 | Inquiry | ||
Aprepitant |
3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-;3H-1,2,4-Triazol-3-one,5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,[2R-[2α(R*),3α]]-;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;L 754030;MK 869;Aprepitant;MK 0869;Emend;ONO 7436;221350-96-5 |
170729-80-3 | Inquiry | |
Bortezomib |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | Inquiry | |
Bosutinib |
3-Quinolinecarbonitrile,4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-;4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;SKI 606;Bosutinib;SK 606;Bosulif;KIN 001-160 |
380843-75-4 | Inquiry | |
Brinzolamide |
2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,(4R)-;2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,(R)-;AL 4862;Brinzolamide;(5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2λ6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide;153191-05-0 |
138890-62-7 | Inquiry | |
bromopentafluorobenzene |
Benzene,1-bromo-2,3,4,5,6-pentafluoro-;Benzene,bromopentafluoro-;1-Bromo-2,3,4,5,6-pentafluorobenzene;Bromoperfluorobenzene;Bromopentafluorobenzene;Pentafluorobromobenzene;Pentafluorophenyl bromide;NSC 21630 |
344-04-7 | Inquiry | |
Canertinib |
2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-,hydrochloride (1:2);2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-,dihydrochloride;PD 183805;Canertinib dihydrochloride;CI 1033;338796-35-3 |
289499-45-2 | Inquiry | |
Cefamandole Nafate |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,sodium salt (1:1),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt,[6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt,(6R,7R)-;Cefamandole nafate;Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate;O-Formylcefamandole sodium;Cefamandole formate sodium;Cephamandole nafate;Mandol;Kefadol;Sodium O-formylcefamandole;Neocefal;Mandokef;Mandolsan;Cemandil;Pavecef;Kefandol;Bergacef;Cefiran;Cefam;Fado;Lampomandol;Cedol;Cemado;NSC 299588 |
42540-40-9 | Inquiry | |
Cefminox Sodium |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,hydrochloride (2:1),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,hydrochloride (2:1),[6R-[6α,7β(Z)]]-;Cefmenoxime hemihydrochloride;Cefmenoxime hydrochloride;Bestcall;Tacef;Abbott 50192;Cemix;Cefmax;Bestron |
75738-58-8 | Inquiry | |
Celecoxib |
Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;Celecoxib;SC 58635;YM 177;Celebrex;Celocoxib;Celebra;Celecox;Xilebao;Medicoxib;Eurocox;Onsenal;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;184007-95-2;194044-54-7 |
169590-42-5 | Inquiry | |
Cinacalcet |
1-Naphthalenemethanamine,α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-,hydrochloride (1:1),(αR)-;1-Naphthalenemethanamine,α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-,hydrochloride,(αR)-;AMG 073 HCl;Cinacalcet hydrochloride;KRN 1493;Sensipar;Mimpara;Regpara;N-[(1R)-1-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride;[(1R)-1-(Naphthalen-1-yl)ethyl]([3-[3-(trifluoromethyl)phenyl]propyl])amine hydrochloride |
364782-34-3 | Inquiry | |
Cizolirtine |
(R)-Cizolirtine;UNII-WL3JTG8V2H;WL3JTG8V2H;R-Cizolirtine;Cizolirtine, (+)-;(R)-(+)-Cizolirtine;CHEMBL92357;SCHEMBL2776433;N,N-dimethyl-2-[(R)-(2-methylpyrazol-3-yl)-phenylmethoxy]ethanamine;Ethanamine, N,N-dimethyl-2-((R)-(1-methyl-1H-pyrazol-5-yl)phenylmethoxy)- |
148981-62-8 | Inquiry | |
Cladribine |
Adenosine,2-chloro-2′-deoxy-;2-Chloro-2′-deoxyadenosine;2-Chloro-2′-deoxy-β-adenosine;2-Chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine;2-Chlorodeoxyadenosine;NSC 105014-F;Cladribine;RWJ 26251;Leustatin;2-CdA;Cladarabine;NSC 105014;CldAdo;Jk 6251;Biodribin;Leustat;(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;Vero-Cladribine;Mavenclad;Litak;24757-90-2 |
4291-63-8 | Inquiry | |
Dapoxetine |
DL-Dapoxteine HCL;N,N-DiMethyl-1-phenyl-3-(1-naphthalenyloxy)propanaMinehydrochloride;(S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride;Dapoxetine/Dapoxetine HCl/Dapoxetine hydrochloride;LY-210448 hydrochloride;Priligy;PRILIGY;LY-210448 HYDROCHLORIDE;(S)-N,N-dimethyl-3- |
129938-20-1 | Inquiry | |
Dasatinib |
5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;BMS 354825;Dasatinib;BMS 35482513;Sprycel;Spyrcel;BMS 345825;KIN 001-5;NSC 759877 |
302962-49-8 | Inquiry |
CONTACT INFORMATION
Sign In for Details